Addressing inequality of health care

IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Medical Journal of Australia Pub Date : 2025-02-16 DOI:10.5694/mja2.52601
Michael Skilton
{"title":"Addressing inequality of health care","authors":"Michael Skilton","doi":"10.5694/mja2.52601","DOIUrl":null,"url":null,"abstract":"<p>Inequality in access to health services and the rising cost of the health system are both challenges to the Australian health system (https://www.health.gov.au/about-us/the-australian-health-system). A number of articles in this issue of the <i>MJA</i> are relevant to describing the nature of these challenges and how they may be addressed.</p><p>The National Disability Insurance Scheme (NDIS) replaced a disability care system that was inequitable and provided limited choice and access to appropriate support. The self-directed nature of the NDIS is designed to, at least in part, overcome these limitations and address deeply rooted barriers that hinder people with disability from fully engaging in society. In this issue, Disney and colleagues used NDIS data to quantify the inequalities in the allocation and use of NDIS support (https://doi.org/10.5694/mja2.52594). They found that older applicants, those who are women or girls, and those living in socio-economically disadvantaged areas are less likely to be deemed eligible for the NDIS. As Smith-Merry and Chang note in their associated editorial (https://doi.org/10.5694/mja2.52587), inequality of access is linked to social inequities, in addition to providing guidance for future research to inform a more tailored and inclusive approach to support provision.</p><p>Obesity is a major contributor to the burden of disease in Australia and is strongly linked with social inequalities and disadvantage. After the failure of so many previous anti-obesity medications (https://journals.biologists.com/dmm/article/5/5/621/3257/Anti-obesity-drugs-past-present-and-future), the glucagon-like peptide-1 (GLP-1) receptor agonists provide perhaps a glimpse of light at the end of the tunnel. Supported by strong evidence of both weight loss and broader health benefits, and amidst a wave of viral celebrity engagement, their worldwide usage has skyrocketed. Within this context, Kanellis and colleagues discuss the role of GLP-1 receptor agonists in obesity (https://doi.org/10.5694/mja2.52582), with a specific focus on identifying funding models and models of care relevant for Australia. By addressing these challenges, the potential of GLP-1 receptor agonists to revolutionise obesity care in a sustainable and equitable manner can be fully realised.</p><p>There are also challenges on the individual level for patients. The decline in bulk-billing by general practitioners and the current cost of living crisis have affected affordability of health care for many people. Through analysis of Medicare bulk-billing rates and out-of-pocket costs for non-bulk-billed general practitioner services, Saxby and Zhang highlight the differences in access to affordable health care on the basis of geographic region, with those in remote and socio-economically disadvantaged areas of Australia having the highest out-of-pocket costs (https://doi.org/10.5694/mja2.52562). In their associated editorial, Rosenberg and Hickie describe three issues that require redress to improve the system to a level of fairness expected by the average Australian (https://doi.org/10.5694/mja2.52580).</p><p>And finally, a medical history article that has less to do with modern challenges to the health care system, but rather provides a glimpse of health care challenges under extreme circumstances. Ariotti and Roberts-Pederson present a fascinating look at the diaries written from inside the Changi prison camp complex by prisoner-of-war Australian medical officer Major Kennedy Burnside (https://doi.org/10.5694/mja2.52581). For the thousands of his fellow prisoners-of-war in Changi, his work there played an important role in minimising the impact of their living conditions on their health. Key aspects of his work highlighted include the diagnosis, treatment and prevention of malaria and the development of a dysentery vaccine. The photos that accompany the article, taken by Burnside, provide an insight into the nature of the pathology laboratory that he established and an intriguing glimpse of life within the complex. I would recommend readers to take the time to view the full collection available on the Australian War Memorial website.</p><p>In one thought-provoking section, the authors detail how Major Burnside pondered whether his endeavours while a prisoner-of-war would have any relevance to his post-war career; he went on to have an illustrious career in medicine. Irrespective of his post-war career achievements, the value of what he did in that period, under those circumstances, cannot be overstated. In the words of Ralph Waldo Emerson, “The reward of a thing well done, is to have done it”.</p>","PeriodicalId":18214,"journal":{"name":"Medical Journal of Australia","volume":"222 3","pages":"109"},"PeriodicalIF":6.7000,"publicationDate":"2025-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.5694/mja2.52601","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Journal of Australia","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.5694/mja2.52601","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Inequality in access to health services and the rising cost of the health system are both challenges to the Australian health system (https://www.health.gov.au/about-us/the-australian-health-system). A number of articles in this issue of the MJA are relevant to describing the nature of these challenges and how they may be addressed.

The National Disability Insurance Scheme (NDIS) replaced a disability care system that was inequitable and provided limited choice and access to appropriate support. The self-directed nature of the NDIS is designed to, at least in part, overcome these limitations and address deeply rooted barriers that hinder people with disability from fully engaging in society. In this issue, Disney and colleagues used NDIS data to quantify the inequalities in the allocation and use of NDIS support (https://doi.org/10.5694/mja2.52594). They found that older applicants, those who are women or girls, and those living in socio-economically disadvantaged areas are less likely to be deemed eligible for the NDIS. As Smith-Merry and Chang note in their associated editorial (https://doi.org/10.5694/mja2.52587), inequality of access is linked to social inequities, in addition to providing guidance for future research to inform a more tailored and inclusive approach to support provision.

Obesity is a major contributor to the burden of disease in Australia and is strongly linked with social inequalities and disadvantage. After the failure of so many previous anti-obesity medications (https://journals.biologists.com/dmm/article/5/5/621/3257/Anti-obesity-drugs-past-present-and-future), the glucagon-like peptide-1 (GLP-1) receptor agonists provide perhaps a glimpse of light at the end of the tunnel. Supported by strong evidence of both weight loss and broader health benefits, and amidst a wave of viral celebrity engagement, their worldwide usage has skyrocketed. Within this context, Kanellis and colleagues discuss the role of GLP-1 receptor agonists in obesity (https://doi.org/10.5694/mja2.52582), with a specific focus on identifying funding models and models of care relevant for Australia. By addressing these challenges, the potential of GLP-1 receptor agonists to revolutionise obesity care in a sustainable and equitable manner can be fully realised.

There are also challenges on the individual level for patients. The decline in bulk-billing by general practitioners and the current cost of living crisis have affected affordability of health care for many people. Through analysis of Medicare bulk-billing rates and out-of-pocket costs for non-bulk-billed general practitioner services, Saxby and Zhang highlight the differences in access to affordable health care on the basis of geographic region, with those in remote and socio-economically disadvantaged areas of Australia having the highest out-of-pocket costs (https://doi.org/10.5694/mja2.52562). In their associated editorial, Rosenberg and Hickie describe three issues that require redress to improve the system to a level of fairness expected by the average Australian (https://doi.org/10.5694/mja2.52580).

And finally, a medical history article that has less to do with modern challenges to the health care system, but rather provides a glimpse of health care challenges under extreme circumstances. Ariotti and Roberts-Pederson present a fascinating look at the diaries written from inside the Changi prison camp complex by prisoner-of-war Australian medical officer Major Kennedy Burnside (https://doi.org/10.5694/mja2.52581). For the thousands of his fellow prisoners-of-war in Changi, his work there played an important role in minimising the impact of their living conditions on their health. Key aspects of his work highlighted include the diagnosis, treatment and prevention of malaria and the development of a dysentery vaccine. The photos that accompany the article, taken by Burnside, provide an insight into the nature of the pathology laboratory that he established and an intriguing glimpse of life within the complex. I would recommend readers to take the time to view the full collection available on the Australian War Memorial website.

In one thought-provoking section, the authors detail how Major Burnside pondered whether his endeavours while a prisoner-of-war would have any relevance to his post-war career; he went on to have an illustrious career in medicine. Irrespective of his post-war career achievements, the value of what he did in that period, under those circumstances, cannot be overstated. In the words of Ralph Waldo Emerson, “The reward of a thing well done, is to have done it”.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
Medical Journal of Australia
Medical Journal of Australia 医学-医学:内科
CiteScore
9.40
自引率
5.30%
发文量
410
审稿时长
3-8 weeks
期刊介绍: The Medical Journal of Australia (MJA) stands as Australia's foremost general medical journal, leading the dissemination of high-quality research and commentary to shape health policy and influence medical practices within the country. Under the leadership of Professor Virginia Barbour, the expert editorial team at MJA is dedicated to providing authors with a constructive and collaborative peer-review and publication process. Established in 1914, the MJA has evolved into a modern journal that upholds its founding values, maintaining a commitment to supporting the medical profession by delivering high-quality and pertinent information essential to medical practice.
期刊最新文献
Methylphenidate and (lis)dexamfetamine toxicity-related deaths of adults, Australia, 2000-24: analysis of NCIS data. Issue Information Addressing inequality of health care Equity first: mapping who gets what is essential to re-designing the NDIS Social inequalities in eligibility rates and use of the Australian National Disability Insurance Scheme, 2016–22: an administrative data analysis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1